Search - tctmd.com

Displaying 1 - 20 of 345

Sort: Relevancy | Date

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

News Daily News

Nonatherosclerotic Causes of MI Common in Younger Patients

L.A. McKeown

September 17, 2025

News Conference News ESC 2025

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

Todd Neale

September 03, 2025

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Todd Neale

July 25, 2025

News Conference News SCCT 2025

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges

Yael L. Maxwell

July 25, 2025

News Daily News

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

Todd Neale

July 09, 2025

News Daily News

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

Yael L. Maxwell

June 25, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Michael O'Riordan

June 06, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

Advertisement

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

Nonatherosclerotic Causes of MI Common in Younger Patients

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

April 2025 Dispatch for the CV Team

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content